These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 11153746

  • 1. Late rejection is a predictor of transplant coronary artery disease in children.
    Mulla NF, Johnston JK, Vander Dussen L, Beeson WL, Chinnock RE, Bailey LL, Larsen RL.
    J Am Coll Cardiol; 2001 Jan; 37(1):243-50. PubMed ID: 11153746
    [Abstract] [Full Text] [Related]

  • 2. Dobutamine stress echocardiography for assessing coronary artery disease after transplantation in children.
    Larsen RL, Applegate PM, Dyar DA, Ribeiro PA, Fritzsche SD, Mulla NF, Shirali GS, Kuhn MA, Chinnock RE, Shah PM.
    J Am Coll Cardiol; 1998 Aug; 32(2):515-20. PubMed ID: 9708485
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influence of acute rejection episodes, HLA matching, and donor/recipient phenotype on the development of 'early' transplant-associated coronary artery disease.
    Hornick P, Smith J, Pomerance A, Mitchell A, Banner N, Rose M, Yacoub M.
    Circulation; 1997 Nov 04; 96(9 Suppl):II-148-53. PubMed ID: 9386090
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Late rejection episodes more than 1 year after pediatric heart transplantation: risk factors and outcomes.
    Webber SA, Naftel DC, Parker J, Mulla N, Balfour I, Kirklin JK, Morrow R, Pediatric Heart Transplant Study Group.
    J Heart Lung Transplant; 2003 Aug 04; 22(8):869-75. PubMed ID: 12909466
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation.
    Jurcevic S, Ainsworth ME, Pomerance A, Smith JD, Robinson DR, Dunn MJ, Yacoub MH, Rose ML.
    Transplantation; 2001 Apr 15; 71(7):886-92. PubMed ID: 11349721
    [Abstract] [Full Text] [Related]

  • 12. Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient.
    Gao SZ, Schroeder JS, Alderman EL, Hunt SA, Silverman JF, Wiederhold V, Stinson EB.
    Circulation; 1987 Nov 15; 76(5 Pt 2):V56-61. PubMed ID: 3311457
    [Abstract] [Full Text] [Related]

  • 13. Clinical experience with cardiac retransplantation.
    Michler RE, McLaughlin MJ, Chen JM, Geimen R, Schenkel F, Smith CR, Barr ML, Rose EA.
    J Thorac Cardiovasc Surg; 1993 Oct 15; 106(4):622-9; discussion 629-31. PubMed ID: 8412255
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pediatric cardiac retransplantation: intermediate-term results.
    Dearani JA, Razzouk AJ, Gundry SR, Chinnock RE, Larsen RL, del Rio MJ, Johnston JK, Bailey LL.
    Ann Thorac Surg; 2001 Jan 15; 71(1):66-70. PubMed ID: 11216812
    [Abstract] [Full Text] [Related]

  • 16. Pediatric recipient survival beyond 15 post-heart transplant years: a single-center experience.
    Copeland H, Razzouk A, Chinnock R, Deming D, Hasaniya N, Bailey L.
    Ann Thorac Surg; 2014 Dec 15; 98(6):2145-50; discussion 2150-1. PubMed ID: 25443019
    [Abstract] [Full Text] [Related]

  • 17. Reliability of tissue Doppler wall motion monitoring after heart transplantation for replacement of invasive routine screenings by optimally timed cardiac biopsies and catheterizations.
    Dandel M, Hummel M, Müller J, Wellnhofer E, Meyer R, Solowjowa N, Ewert R, Hetzer R.
    Circulation; 2001 Sep 18; 104(12 Suppl 1):I184-91. PubMed ID: 11568053
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Survival benefit in heart transplant recipients who have coronary artery disease confirmed using angiography and are receiving sirolimus.
    Zakliczynski M, Swierad M, Nozynski J, Maruszewski M, Zembala M.
    Transplant Proc; 2009 Sep 18; 41(1):285-8. PubMed ID: 19249536
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.